Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

计划入组 500 人 · 首次发布于 2020 年 9 月 14 日

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

计划入组 110 人 · 首次发布于 2007 年 8 月 9 日

SCS Research Study

计划入组 100 人 · 首次发布于 2018 年 12 月 4 日

Gene therapy(Janssen Global Services LLC)

Schizophrenia Therapeutics(Janssen Global Services LLC)

Cancer vaccine(Janssen Global Services LLC)

GEM PHARMACEUTICALS

India

ProgenaCare Global, LLC

United States

Global Medical, LLC

United States

GEM Commits Up to NT$500 Million to Senhwa Biosciences to Advance Oncology Pipeline

Clearside Biomedical Highlights Suprachoroidal Delivery Tech at Global Medical Meetings

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues